Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospital

被引：27
作者：
Freeman, J
Stott, J
Baines, SD
Fawley, WN
Wilcox, MH [1 ]
机构：
[1] Univ Leeds, Dept Microbiol, Leeds LS2 9JT, W Yorkshire, England
[2] Gen Infirm, Leeds LS2 9JT, W Yorkshire, England
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2005年 / 56卷 / 05期
关键词：
C; difficile; infections; treatment;
D O I：
10.1093/jac/dki357
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：988 / 989
页数：3
相关论文
共 10 条
[1]   Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997 [J].
Barbut, F ;
Decré, D ;
Burghoffer, B ;
Lesage, D ;
Delisle, F ;
Lalande, V ;
Delmée, M ;
Avesani, V ;
Sano, N ;
Coudert, C ;
Petit, JC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2607-2611
[2]   Reduced susceptibility of Clostridium difficile to metronidazole [J].
Brazier, JS ;
Fawley, W ;
Freeman, J ;
Wilcox, MH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (05) :741-742
[3]   Molecular epidemiology of endemic Clostridium difficile infection [J].
Fawley, WN ;
Wilcox, MH .
EPIDEMIOLOGY AND INFECTION, 2001, 126 (03) :343-350
[4]   Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection [J].
Freeman, J ;
Baines, SD ;
Jabes, D ;
Wilcox, MH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (04) :717-725
[5]   Metronidazole for Clostridium difficile-associated disease:: Is it okay for mom? [J].
Gerding, DN .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (11) :1598-1600
[6]   Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole [J].
Musher, DM ;
Aslam, S ;
Logan, N ;
Nallacheru, S ;
Bhaila, I ;
Borchert, F ;
Hamill, RJ .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (11) :1586-1590
[7]   Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin [J].
Peláez, T ;
Alcalá, L ;
Alonso, R ;
Rodríguez-Créixems, M ;
García-Lechuz, JM ;
Bouza, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :1647-1650
[8]   Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada [J].
Pépin, J ;
Alary, ME ;
Valiquette, L ;
Raiche, E ;
Ruel, J ;
Fulop, K ;
Godin, D ;
Bourassa, C .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (11) :1591-1597
[9]   Metronidazole susceptibility in Clostridium difficile isolates recovered from cases of C-difficile-associated disease treatment failures and successes [J].
Sanchez, JL ;
Gerding, DN ;
Olson, MM ;
Johnson, S .
ANAEROBE, 1999, 5 (3-4) :201-204
[10]   Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest [J].
Wong, SSY ;
Woo, PCY ;
Luk, WK ;
Yuen, KY .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 34 (01) :1-6
1